Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China flag China · Delayed Price · Currency is CNY
10.36
-0.28 (-2.63%)
Apr 8, 2026, 3:00 PM CST

SHA:600267 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,2921,4981,5871,3991,296
Trading Asset Securities
2.37-0.29-3.05
Cash & Short-Term Investments
1,2951,4981,5871,3991,299
Cash Growth
-13.56%-5.63%13.45%7.70%-36.93%
Accounts Receivable
1,9041,9182,0662,5532,239
Other Receivables
196.09203.59411.65249.57414.04
Receivables
2,1012,1222,4782,8022,653
Inventory
1,6871,7951,9571,9142,023
Other Current Assets
328.94247.25337.33294.12389.29
Total Current Assets
5,4115,6616,3596,4096,364
Property, Plant & Equipment
7,0617,5668,2529,1019,754
Long-Term Investments
1,4841,4501,4151,4821,383
Goodwill
----1.42
Other Intangible Assets
848.67946.661,0731,3371,419
Long-Term Deferred Tax Assets
146.32175.22179.6296.17118.58
Long-Term Deferred Charges
7.6653.28176.26194.45187.17
Other Long-Term Assets
92.72119.68159.02158.75146.69
Total Assets
15,05215,97217,61318,77819,374
Accounts Payable
1,1811,0791,1441,3031,037
Accrued Expenses
444.211,4091,6121,5851,617
Short-Term Debt
1,9802,1612,1573,0054,491
Current Portion of Long-Term Debt
887.36908.831,048313.86557.01
Current Portion of Leases
-14.6510.6910.7511.64
Current Income Taxes Payable
246.3259.2834.7459.8344.95
Current Unearned Revenue
81.8491.49106.5119.05268.42
Other Current Liabilities
1,012414.08469.87736.82757.82
Total Current Liabilities
5,8336,1386,5847,1338,785
Long-Term Debt
1551,0072,3683,0572,758
Long-Term Leases
49.4158.3129.1532.3837.56
Long-Term Unearned Revenue
137.17164.58185.96207.15216.28
Long-Term Deferred Tax Liabilities
25.0725.2522.6317.9720.73
Other Long-Term Liabilities
--74.08-211.12
Total Liabilities
6,2007,3939,26410,44812,029
Common Stock
1,1991,1991,2081,1981,196
Additional Paid-In Capital
4,3324,2914,3464,1633,511
Retained Earnings
3,4333,1382,5362,8292,500
Treasury Stock
-367.28-299.4-341.15-549.56-337.73
Comprehensive Income & Other
10.7413.12353.08439.19433.98
Total Common Equity
8,6078,3418,1028,0797,303
Minority Interest
244.44237.66247.44251.142.23
Shareholders' Equity
8,8528,5798,3498,3307,346
Total Liabilities & Equity
15,05215,97217,61318,77819,374
Total Debt
3,0724,1505,6136,4197,855
Net Cash (Debt)
-1,777-2,652-4,026-5,020-6,556
Net Cash Per Share
-1.51-2.27-3.46-4.31-5.79
Filing Date Shares Outstanding
1,2451,1691,1781,1881,196
Total Common Shares Outstanding
1,2451,1691,1891,1721,196
Working Capital
-422.65-476.51-224.79-723.95-2,421
Book Value Per Share
6.917.146.816.896.11
Tangible Book Value
7,7597,3957,0296,7425,883
Tangible Book Value Per Share
6.236.335.915.754.92
Buildings
-6,0325,9695,6695,608
Machinery
-9,1658,6608,4458,115
Construction In Progress
-216.84688.391,2441,541
Source: S&P Global Market Intelligence. Standard template. Financial Sources.